ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Intestinal MicrobiOMICS to Define Health and Disease in Human and Mice

Serino, Matteo*; Chabo, Chantal; Burcelin, Remy
CURRENT PHARMACEUTICAL BIOTECHNOLOGY2012-4DOI: 10.2174/138920112799857567
34被引3阅读
引用收藏
分享

摘要

Over the last five years an increasing effort has been made to understand the role of intestinal microbiota in health and disease, resulting in regarding to it as a new organ actively involved in the control of host metabolism, both in humans and mice. Amongst hundreds (up to thousand) germ species inhabiting the intestine, few of them are cultivable. Nevertheless, next-generation sequencing-based molecular technologies have been developed, allowing to overcome this problem and shed light on the way the gut microbiota undergoes dramatic changes during (patho)-physiological modifications of the host. Hence, the study of the overall gut germ genome (metagenome) and transcriptome (microbiome) has been launched. Thus, Genomics and Transcriptomics have begun to be increasingly used, opening the so called "Omics" era, including Proteomics and Metabolomics techniques as well. Taken together, the "Omics" allow the study of gut microbiota impact on whole host metabolism, resulting in the definition of new metabolic profiles (i.e. the presence of metabolites within the blood defines a metabolomic profile), others than those based on nucleic acid analyses only. Once demonstrated the involvement of gut microbiota within metabolic diseases, "Omics" analyses has allowed the identification of the obesity-induced gut microbiota imbalance, characterized by increased Firmicutes to Bacteroidetes ratio (metagenomics) and of the so called "core microbiome", focusing on the gut microbiota at a gene-rather than, solely, at a taxonomic-level. In addition, metabolomics studies revealed, for instance, the implication of gut microbiota to nonalcoholic fatty liver disease in insulin-resistant mice. Additionally, the use of germ-free (axenic) mice has made possible the microflora transfer to investigate the mechanisms through which gut microbes modulate host metabolism, albeit the molecular actors of the host-gut-microbiota interplay remain to be fully determined. Here, we report the role of "Omics" in the multiple analyses of gut microbiota-driven metabolic modifications of the host, proposing also to focus on lipopolysaccharides (LPS), the Gram negative proinflammatory molecules we already showed to be the initiators of metabolic diseases.

学科与关键词

关键词
Axenic-micegut microbiotahigh-fat dietinflammationlipopolysaccharidesmetabolic diseasesmicrobiome16S rRNA PCRshotgun-sequencing
相关
加载中…
  • Metabolomics: towards understanding host-microbe interactions
    Han, Jun; Antunes, L. Caetano M.; Finlay, B. Brett; Borcherst, Christoph H.*Future Microbiology, 2010, 5(2): 153-161.被引 37
  • Coordinated regulation of the metabolome and lipidome at the host-microbial interface
    Backhed, Fredrik; Crawford, Peter A.Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, 2010, 1801(3): 240-245.被引 65
  • The Human Gutome: Nutrigenomics of the Host-Microbiome Interactions
    Dimitrov, Dimiter V.*OMICS A Journal of Integrative Biology, 2011, 15(7-8): 419-430.被引 40
查看全部 →

发表信息

论文状态
公开发表
期刊
CURRENT PHARMACEUTICAL BIOTECHNOLOGY
发表日期
2012-04
卷期
第 13 卷, 第 5 期
页码
746-758
DOI
10.2174/138920112799857567
语言
ENGLISH
成果收录
SCIE

作者

  • S

    Serino, Matteo (通讯) (第一作者)

  • C

    Chabo, Chantal

查看全部 3 位作者收起作者
  • B

    Burcelin, Remy

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417